Medi First Plus Antacid
- Manufacturer
- Unifirst First Aid Corporation
- Effective date
- 2022-03-15
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 15
- Source
- full-release
- Hydrated at
- 2026-05-31 23:48:44
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
Active ingredient (in each tablet)
Calcium Carbonate 420 mg
OTC - PURPOSE SECTION
Purpose
Antacid
INDICATIONS & USAGE SECTION
Uses
relieves
- acid indigestion
- sour stomach
- heartburn
- upset stomach associated with these symptoms
WARNINGS SECTION
Warnings
OTC - DO NOT USE SECTION
Do not use
■ the maximum dosage of this product for more than 2 weeks except under the advice and supervision of a
doctor
OTC - ASK DOCTOR/PHARMACIST SECTION
Ask a doctor or pharmacist before use if you
■ are taking a prescription drug. Antacids may interact with certain prescription drugs.
■ have kidney disease
OTC - WHEN USING SECTION
When using this product
- do not take more than 19 tablets in a 24 hour period. If symptoms persist for more than two weeks, stop using this product and see a doctor.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast feeding ,ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of the reach of children.
DOSAGE & ADMINISTRATION SECTION
Directions
Adults and children: (12 years and older) Chew 2 tablets every 2 - 3 hours or as symptoms occur, repeat hourly if needed. Do not exceed 19 tablets in 24 hours.
Children under 12 years: Ask a doctor
SPL UNCLASSIFIED SECTION
Other information
- calcium content per tablet: 168 mg
- phenylketonurics: each tablet may contain 1.5 mg phenylalanine
- store at room temperature 59-86°F (15-30°C) in a dry place
- tamper-evident sealed packets
- do not use any opened or torn packets
INACTIVE INGREDIENT SECTION
Inactive ingredients
aspartame*, croscarmellose sodium*, gum acacia*, magnesium stearate, maltodextrin, mineral oil*, mint flavor, sorbitol*, sucrose*
*may contain
OTC - QUESTIONS SECTION
Questions or comments Call 1-800-634-7680
Medi-First Plus Antacid Label
100 Tablets
(50 x 2's)
MEDI-FIRST® Plus
Antacid
Calcium Carbonate 420mg
Carbonato de Calcio 420mg
Pull to Open
Tire Para Abrir
Calcium Rich
Chewable Tablets
Tabletas Masticables, Ricas en Calcio
Compare active ingredient to:
TUMS®
Registered Trademark of Smithkline-Beecham
Tamper Evident
Unit Dose Packets
Empaquetado con sellado
evidente en dosis unitarias
Medi-First Antacid Label
100
Tablets
(50 x 2)
MEDI-FIRST ®
Antacid Calcium Carbonate
Compare active ingredient to:
Compare el ingrediente activo con:
Tums ®
Registered Trademark of Smithkline-Beecham
Marca Registrada de Smithkline-Beecham
Pull to Open
Tire Para Abrir
Heartburn, Indigestion • Calcium Carbonate 420mg
las agruras, la indigestion • Antiacido Carbonato de Calcio 420mg
Antiacido Carbonato de Calico
Tamper Evident Unit Dose Packets
Empaquetado con Sellado Evidente en Dosis Unitarias
Medique Alcalak Label
Medique ®
Alcalak
Calcium-Rich Antacid
Mint Flavor
Heartburn, Indigestion • Calcium Carbonate 420 mg
6
Tablets
(3 x 2)
Tamper Evident Unit Dose Packets
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bee4fa8d-8d82-423a-a0b5-40a89dd13a99 | Product name | 1 | 20250618 |
| e0d2eb29-08bd-4bba-90d1-c91c68a38767 | Product name | 4 | 20250516 |
| 30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2 | Product name | 5 | 20250304 |
| 334fe8d2-68fb-4331-a576-420e302ec069 | Product name | 7 | 20240320 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| e92765c1-be81-432a-b909-1b10777ec378 | Product name | 1 | 20190208 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 0441a8f5-3835-497c-aedd-bc78cba56b2a | Product name | 1 | 20150317 |
| 87711080-88eb-65c5-b2dd-bf99e700a372 | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 47682-088-13 | Medique Alcalak | 250 in 1 BOX | TABLET, CHEWABLE | 250 | 15 | |
| 47682-088-13 | Medique Alcalak | 2 in 1 PACKET | TABLET, CHEWABLE | 2 | 15 | |
| 47682-088-33 | Medique Alcalak | 50 in 1 BOX | TABLET, CHEWABLE | 50 | 15 | |
| 47682-088-33 | Medique Alcalak | 2 in 1 PACKET | TABLET, CHEWABLE | 2 | 15 | |
| 47682-088-47 | Medique Alcalak | 100 in 1 BOX | TABLET, CHEWABLE | 100 | 15 | |
| 47682-088-64 | Medique Alcalak | 2 in 1 PACKET | TABLET, CHEWABLE | 2 | 15 | |
| 47682-088-64 | Medique Alcalak | 12 in 1 BOX | TABLET, CHEWABLE | 12 | 15 | |
| 47682-088-69 | Medique Alcalak | 2 in 1 PACKET | TABLET, CHEWABLE | 2 | 15 | |
| 47682-088-69 | Medique Alcalak | 3 in 1 BOX | TABLET, CHEWABLE | 3 | 15 | |
| 47682-088-99 | Medique Alcalak | 2 in 1 PACKET | TABLET, CHEWABLE | 2 | 15 | |
| 47682-089-13 | Medi First Antacid | 250 in 1 BOX | TABLET, CHEWABLE | 250 | 15 | |
| 47682-089-13 | Medi First Antacid | 2 in 1 PACKET | TABLET, CHEWABLE | 2 | 15 | |
| 47682-089-33 | Medi First Antacid | 50 in 1 BOX | TABLET, CHEWABLE | 50 | 15 | |
| 47682-089-48 | Medi First Antacid | 2 in 1 PACKET | TABLET, CHEWABLE | 2 | 15 | |
| 47682-089-48 | Medi First Antacid | 125 in 1 BOX | TABLET, CHEWABLE | 125 | 15 | |
| 47682-089-50 | Medi First Antacid | 25 in 1 BOX | TABLET, CHEWABLE | 25 | 15 | |
| 47682-089-50 | Medi First Antacid | 2 in 1 PACKET | TABLET, CHEWABLE | 2 | 15 | |
| 47682-089-99 | Medi First Antacid | 2 in 1 PACKET | TABLET, CHEWABLE | 2 | 15 | |
| 47682-092-33 | Medi First Plus Antacid | 50 in 1 BOX | TABLET, CHEWABLE | 50 | 15 | |
| 47682-092-33 | Medi First Plus Antacid | 2 in 1 PACKET | TABLET, CHEWABLE | 2 | 15 | |
| 47682-092-48 | Medi First Plus Antacid | 125 in 1 BOX | TABLET, CHEWABLE | 125 | 15 | |
| 47682-092-48 | Medi First Plus Antacid | 2 in 1 PACKET | TABLET, CHEWABLE | 2 | 15 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 47682-088 | MEDIQUE ALCALAK (CALCIUM CARBONATE) TABLET, CHEWABLE MEDI FIRST ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE MEDI FIRST PLUS ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE [UNIFIRST FIRST AID CORPORATION] | 15 | Legacy NDC, 10 package rows | 20220316_7ccd8e04-4bbb-4465-a81f-a8b2bc6b9b9b.zip |
| 47682-089 | MEDIQUE ALCALAK (CALCIUM CARBONATE) TABLET, CHEWABLE MEDI FIRST ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE MEDI FIRST PLUS ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE [UNIFIRST FIRST AID CORPORATION] | 15 | Legacy NDC, 8 package rows | 20220316_7ccd8e04-4bbb-4465-a81f-a8b2bc6b9b9b.zip |
| 47682-092 | MEDIQUE ALCALAK (CALCIUM CARBONATE) TABLET, CHEWABLE MEDI FIRST ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE MEDI FIRST PLUS ANTACID (CALCIUM CARBONATE) TABLET, CHEWABLE [UNIFIRST FIRST AID CORPORATION] | 15 | Legacy NDC, 4 package rows | 20220316_7ccd8e04-4bbb-4465-a81f-a8b2bc6b9b9b.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CALCIUM CARBONATE | ACTIVE INGREDIENT | H0G9379FGK | 5 | |
| CARBONATE ION | ACTIVE MOIETY | 7UJQ5OPE7D | 5 | |
| ACACIA | INACTIVE INGREDIENT | 5C5403N26O | 5 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 5 | |
| MALTODEXTRIN | INACTIVE INGREDIENT | 7CVR7L4A2D | 5 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | 5 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 5 |
Products#
Every source-derived product name is available through these pages.
- Medique Alcalak
- calcium carbonate
- ACACIA
- MAGNESIUM STEARATE
- MALTODEXTRIN
- SUCROSE
- CALCIUM CATION
- CARBONATE ION
- Medi First Antacid
- Medi First Plus Antacid
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 47682-088 | 47682-088-69, 47682-088-64, 47682-088-33, 47682-088-99, 47682-088-47, 47682-088-13 |
| 47682-089 | 47682-089-13, 47682-089-48, 47682-089-99, 47682-089-33, 47682-089-50 |
| 47682-092 | 47682-092-33, 47682-092-48 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACACIA | 5C5403N26O | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| SUCROSE | C151H8M554 | IACT |
| CALCIUM CARBONATE | H0G9379FGK | ACTIB |
| ACACIA | 5C5403N26O | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| SUCROSE | C151H8M554 | IACT |
| CALCIUM CARBONATE | H0G9379FGK | ACTIB |
| ACACIA | 5C5403N26O | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| SUCROSE | C151H8M554 | IACT |
| CALCIUM CARBONATE | H0G9379FGK | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | PASTE / DENTAL | 95 %w/w | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, CHEWABLE / ORAL | 292 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | GRANULE, FOR SUSPENSION / ORAL | 952 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | INSERT / VAGINAL | 69 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER, FOR SUSPENSION / ORAL | 120 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, CHEWABLE / ORAL | 6 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, COATED / ORAL | 5.6 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | GRANULE / ORAL | 629 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / VAGINAL | 402 mg | ||
| ACACIA | ACACIA | 5C5403N26O | GUM, CHEWING / BUCCAL | 280 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 9 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, DELAYED RELEASE / ORAL | 144 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, DELAYED RELEASE / ORAL | 1060 mg | ||
| ACACIA | ACACIA | 5C5403N26O | LOZENGE / ORAL | 108 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| ACACIA | ACACIA | 5C5403N26O | POWDER, FOR SUSPENSION / ORAL | 7386 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET, FILM COATED / ORAL | 0.14 mg | ||
| ACACIA | ACACIA | 5C5403N26O | POWDER, FOR SOLUTION / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 308 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET / ORAL | 113.75 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | DROPS / ORAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / VAGINAL | 30 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / OPHTHALMIC | 0.1 %w/w | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| ACACIA | ACACIA | 5C5403N26O | TABLET / SUBLINGUAL | 9.1 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / AURICULAR (OTIC) | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | PELLET / ORAL | 24 mg | ||
| ACACIA | ACACIA | 5C5403N26O | CAPSULE / ORAL | 20 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION / INTRAVENOUS | 1950 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| ACACIA | ACACIA | 5C5403N26O | SUSPENSION / ORAL | 2 mg | ||
| ACACIA | ACACIA | 5C5403N26O | CAPSULE, EXTENDED RELEASE / ORAL | 64 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | WAFER / ORAL | 66 mg | ||
| ACACIA | ACACIA | 5C5403N26O | SYRUP / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 9.4 %w/v | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET / BUCCAL | 109 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CREAM / TOPICAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / RESPIRATORY (INHALATION) | 0.13 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d8dbf727-4d7c-a96f-e053-2995a90ae10d | 7ccd8e04-4bbb-4465-a81f-a8b2bc6b9b9b | 2022-03-15 | Warnings | d8dbf727-4d7c-a96f-e053-2995a90ae10d 7ccd8e04-4bbb-4465-a81f-a8b2bc6b9b9b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


